These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32887653)

  • 1. Effect of chemoprevention by low-dose aspirin of new or recurrent colorectal adenomas in patients with Lynch syndrome (AAS-Lynch): study protocol for a multicenter, double-blind, placebo-controlled randomized controlled trial.
    Soualy A; Deutsch D; Benallaoua M; Ait-Omar A; Mary F; Helfen S; Boubaya M; Levy V; Benamouzig R;
    Trials; 2020 Sep; 21(1):764. PubMed ID: 32887653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
    Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
    Trials; 2013 Jul; 14():237. PubMed ID: 23895505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC).
    Burn J; Mathers J; Bishop DT
    Recent Results Cancer Res; 2013; 191():157-83. PubMed ID: 22893205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial.
    Burn J; Sheth H; Elliott F; Reed L; Macrae F; Mecklin JP; Möslein G; McRonald FE; Bertario L; Evans DG; Gerdes AM; Ho JWC; Lindblom A; Morrison PJ; Rashbass J; Ramesar R; Seppälä T; Thomas HJW; Pylvänäinen K; Borthwick GM; Mathers JC; Bishop DT;
    Lancet; 2020 Jun; 395(10240):1855-1863. PubMed ID: 32534647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
    Burn J; Gerdes AM; Macrae F; Mecklin JP; Moeslein G; Olschwang S; Eccles D; Evans DG; Maher ER; Bertario L; Bisgaard ML; Dunlop MG; Ho JW; Hodgson SV; Lindblom A; Lubinski J; Morrison PJ; Murday V; Ramesar R; Side L; Scott RJ; Thomas HJ; Vasen HF; Barker G; Crawford G; Elliott F; Movahedi M; Pylvanainen K; Wijnen JT; Fodde R; Lynch HT; Mathers JC; Bishop DT;
    Lancet; 2011 Dec; 378(9809):2081-7. PubMed ID: 22036019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial.
    Hull MA; Sprange K; Hepburn T; Tan W; Shafayat A; Rees CJ; Clifford G; Logan RF; Loadman PM; Williams EA; Whitham D; Montgomery AA;
    Lancet; 2018 Dec; 392(10164):2583-2594. PubMed ID: 30466866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.
    Cole BF; Logan RF; Halabi S; Benamouzig R; Sandler RS; Grainge MJ; Chaussade S; Baron JA
    J Natl Cancer Inst; 2009 Feb; 101(4):256-66. PubMed ID: 19211452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.
    Burn J; Bishop DT; Mecklin JP; Macrae F; Möslein G; Olschwang S; Bisgaard ML; Ramesar R; Eccles D; Maher ER; Bertario L; Jarvinen HJ; Lindblom A; Evans DG; Lubinski J; Morrison PJ; Ho JW; Vasen HF; Side L; Thomas HJ; Scott RJ; Dunlop M; Barker G; Elliott F; Jass JR; Fodde R; Lynch HT; Mathers JC;
    N Engl J Med; 2008 Dec; 359(24):2567-78. PubMed ID: 19073976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.
    Higurashi T; Hosono K; Takahashi H; Komiya Y; Umezawa S; Sakai E; Uchiyama T; Taniguchi L; Hata Y; Uchiyama S; Hattori A; Nagase H; Kessoku T; Arimoto J; Matsuhashi N; Inayama Y; Yamanaka S; Taguri M; Nakajima A
    Lancet Oncol; 2016 Apr; 17(4):475-483. PubMed ID: 26947328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating colonoscopy screening intervals in patients with Lynch syndrome from a large Canadian registry.
    Aronson M; Gryfe R; Choi YH; Semotiuk K; Holter S; Ward T; Gallinger S; Cohen Z; Briollais L
    J Natl Cancer Inst; 2023 Jul; 115(7):778-787. PubMed ID: 36964717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the utility and acceptability of Faecal immunochemical testing (FIT) as a novel intervention for the improvement of colorectal Cancer (CRC) surveillance in individuals with lynch syndrome (FIT for lynch study): a single-arm, prospective, multi-centre, non-randomised study.
    Lincoln A; Benton S; Piggott C; North BV; Rigney J; Young C; Quirke P; Sasieni P; Monahan KJ
    BMC Cancer; 2022 Nov; 22(1):1144. PubMed ID: 36344941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chromoendoscopy in the proximal colon on colorectal neoplasia detection in Lynch syndrome: a multicenter randomized controlled trial.
    Haanstra JF; Dekker E; Cats A; Nagengast FM; Hardwick JC; Vanhoutvin SA; de Vos Tot Nederveen Cappel WH; Vasen HF; Kleibeuker JH; Koornstra JJ
    Gastrointest Endosc; 2019 Oct; 90(4):624-632. PubMed ID: 31028782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial.
    Jaszewski R; Misra S; Tobi M; Ullah N; Naumoff JA; Kucuk O; Levi E; Axelrod BN; Patel BB; Majumdar AP
    World J Gastroenterol; 2008 Jul; 14(28):4492-8. PubMed ID: 18680228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
    Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R
    N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention.
    Benamouzig R; Uzzan B; Martin A; Deyra J; Little J; Girard B; Chaussade S;
    Gut; 2010 May; 59(5):622-9. PubMed ID: 20427397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of aspirin to prevent colorectal adenomas.
    Baron JA; Cole BF; Sandler RS; Haile RW; Ahnen D; Bresalier R; McKeown-Eyssen G; Summers RW; Rothstein R; Burke CA; Snover DC; Church TR; Allen JI; Beach M; Beck GJ; Bond JH; Byers T; Greenberg ER; Mandel JS; Marcon N; Mott LA; Pearson L; Saibil F; van Stolk RU
    N Engl J Med; 2003 Mar; 348(10):891-9. PubMed ID: 12621133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial.
    Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A
    BMC Cancer; 2020 Oct; 20(1):1043. PubMed ID: 33121471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients.
    Petrera M; Paleari L; Clavarezza M; Puntoni M; Caviglia S; Briata IM; Oppezzi M; Mislej EM; Stabuc B; Gnant M; Bachleitner-Hofmann T; Roth W; Scherer D; Haefeli WE; Ulrich CM; DeCensi A
    BMC Cancer; 2018 Dec; 18(1):1210. PubMed ID: 30514262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.
    Cole BF; Baron JA; Sandler RS; Haile RW; Ahnen DJ; Bresalier RS; McKeown-Eyssen G; Summers RW; Rothstein RI; Burke CA; Snover DC; Church TR; Allen JI; Robertson DJ; Beck GJ; Bond JH; Byers T; Mandel JS; Mott LA; Pearson LH; Barry EL; Rees JR; Marcon N; Saibil F; Ueland PM; Greenberg ER;
    JAMA; 2007 Jun; 297(21):2351-9. PubMed ID: 17551129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin, Calcitriol, and Calcium Do Not Prevent Adenoma Recurrence in a Randomized Controlled Trial.
    Pommergaard HC; Burcharth J; Rosenberg J; Raskov H
    Gastroenterology; 2016 Jan; 150(1):114-122.e4. PubMed ID: 26404953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.